Ruger Accuses Beretta of Hostile Takeover Attempt, Demanding Discounted Shares & Board Control
RGR sits 35% above its 52-week low of $28.33 on light trading volume (0.2× avg).
Summary
Sturm, Ruger & Co. has publicly accused activist investor Beretta Holding S.A. of attempting a hostile takeover, detailing Beretta's demands for discounted shares and disproportionate board representation.
Key Events · Corporate Governance and Compliance · RGR
-
Hostile Takeover Accusation
Sturm, Ruger & Co. publicly accused Beretta Holding S.A. of attempting a hostile takeover, detailing a history of aggressive demands and threats, including a 'war' if demands were not met.
-
Demands for Discounted Shares
Ruger revealed Beretta demanded to acquire additional shares at a 15% discount, which Ruger states would dilute existing stockholders and transfer value to Beretta.
-
Antitrust & Governance Concerns
Beretta allegedly sought disproportionate board representation, including a Beretta executive, which Ruger claims would violate U.S. antitrust laws and trigger national security review.
-
Defense of Board Actions
Ruger defended its proactive board refreshment and the adoption of a poison pill as necessary measures against Beretta's 'creeping takeover' and aggressive campaign.
Analysis · RGR · Manufacturing
This filing marks a significant escalation in the proxy contest between Sturm, Ruger & Co. and activist investor Beretta Holding S.A. Ruger's detailed press release directly refutes Beretta's claims and reveals specific, aggressive demands made by Beretta, including a 15% discount on shares and board control that Ruger alleges would violate antitrust laws. Investors should note the potential for significant dilution if Beretta's demands for discounted shares were met and the ongoing governance battle creating uncertainty. The company's strong defense highlights the contentious nature of this situation, which is likely to continue impacting investor sentiment and strategic direction.
At the time of this filing, RGR was trading at $38.31 on NYSE in the Manufacturing sector, with a market capitalization of approximately $610.8M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.